Article
New aspects of the clinicopathology and genetic profile of metachronous multiple lung cancers.
Annals of surgery - 1 May 2014
Wu Chen-Tu, Lin Mong-Wei, Hsieh Min-Shu, Kuo Shuenn-Wen, Chang Yih-Leong
Abstract excerpt
OBJECTIVE: For treatment decisions and prognostic applications, we evaluated p53/epidermal growth factor receptor (EGFR) somatic aberrations in metachronous multiple lung cancers to differentiate multiple primary lung cancers (MPLCs) from pulmonary metastases. BACKGROUND: The current criteria to differentiate MPLCs from metastases are based on the histologic type and onset interval and do not incorporate genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
